ReachMD

Episodes 106-120 of 131

• • 

    

    Lisa Kroon, PharmD, CD

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  1

  

  RestartResume

  DPP-4 Inhibitors: A New Class of Medications

• • 

    

    Sandra Bourdette

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  1

  

  RestartResume

  The Importance of Diabetes Education for Patients and Providers

• • 

    

    Sarah Lorentz, PharmD

    Peer

  • 

    

    Candis Morello, PharmD, CDE

    Peer

  1

  

  RestartResume

  The Importance of Immunizations for Diabetic Patients

• • 

    

    Brookie Best, PharmD

    Peer

  • 

    

    Candis Morello, PharmD, CDE

    Peer

  1

  

  RestartResume

  Drug Delivery Systems in the Management of Diabetes

• • 

    

    Daniel Einhorn, MD

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  1

  

  RestartResume

  New AACE Guidelines for Treating Type 2 Diabetes

• • 

    

    David Ward, MD

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  3

  

  RestartResume

  Diabetic Kidney Disease

• • 

    

    Irl Hirsch, MD

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  2

  

  RestartResume

  NICE-SUGAR: Blood Glucose Levels in the ICU

• • 

    

    Thomas Moore, MD

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  3

  

  RestartResume

  Characteristics of Gestational Diabetes

• • 

    

    Steven Edelman, MD

    Peer

  • 

    

    Lorena Drago, MS, RD, CDN, CDE

    Peer

  2

  

  RestartResume

  Weighing Therapeutic Diets for Type 2 Diabetics

• • 

    

    Vivian Fonseca, MD, FRCP

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  3

  

  RestartResume

  Sodium-Glucose Transporters: A New Class of Diabetes Medications

• • 

    

    Ralph A. DeFronzo, MD

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  1

  

  RestartResume

  A New Paradigm for the Treatment of Type 2 Diabetes

• • 

    

    John Buse, MD, PhD

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  1

  

  RestartResume

  Do Incretins Play An Important Role In the Cardiovascular System?

• • 

    

    Kelly Close, MBA

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  2

  

  RestartResume

  The Diabetes Infrastructure: Regulation & Reimbursement

• • 

    

    Robert Henry, MD

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  1

  

  RestartResume

  New Developments in Incretins and SGLT Inhibitors

• • 

    

    Daniel Blanchard, MD

    Peer

  • 

    

    Steven Edelman, MD

    Peer

  1

  

  RestartResume

  A Resurgence of Stents

• Prev
• 1
• 2
• …
• 6
• 7
• 8
• 9
• Next